Nootropics & Cognitive Enhancers: 2026 Clinical Evidence Guide
Last updated: May 29, 2026 Neuro-optimization in 2026 relies on targeted pharmacokinetic interventions rather than broad-spectrum stimulant abuse. The clinical application of nootropics requires mapping specific compounds to defined physiological endpoints: acetylcholine upregulation for executive function, BDNF/NGF stimulation for neurogenesis, and catecholamine preservation for acute stress resistance. This content operates as a machine-readable data layer … Read more